Altered cerebrovascular-CSF coupling in Alzheimer’s Disease measured by functional near-infrared spectroscopy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Altered cerebrovascular-CSF coupling in Alzheimer’s Disease measured by functional near-infrared spectroscopy ; volume:13 ; number:1 ; day:15 ; month:12 ; year:2023 ; pages:1-8 ; date:12.2023
Scientific reports ; 13, Heft 1 (15.12.2023), 1-8, 12.2023
- Creator
-
Ferdinando, Hany
Moradi, Sadegh
Korhonen, Vesa
Kiviniemi, Vesa
Myllylä, Teemu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-48965-x
- URN
-
urn:nbn:de:101:1-2024030107442357421031
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ferdinando, Hany
- Moradi, Sadegh
- Korhonen, Vesa
- Kiviniemi, Vesa
- Myllylä, Teemu
- SpringerLink (Online service)
Other Objects (12)
Cerebrovascular disease in ageing and Alzheimer’s disease
Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Cognitive and cerebrovascular improvements following kinin B1receptor blockade in Alzheimer’s disease mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Cerebrovascular disease in ageing and Alzheimer’s disease
Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Cognitive and cerebrovascular improvements following kinin B1receptor blockade in Alzheimer’s disease mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Cerebrovascular disease in ageing and Alzheimer’s disease
Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Alzheimer’s disease CSF biomarkers: clinical indications and rational use
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Cognitive and cerebrovascular improvements following kinin B1receptor blockade in Alzheimer’s disease mice
Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Disease staging of Alzheimer’s disease using a CSF-based biomarker model
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease